Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
12.74
-0.34 (-2.60%)
At close: Mar 20, 2026, 4:00 PM EDT
12.57
-0.17 (-1.33%)
After-hours: Mar 20, 2026, 6:23 PM EDT
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $771.1 million as of March 20, 2026. Its market cap has increased by 54.86% in one year.
Market Cap
771.10M
Enterprise Value
395.89M
1-Year Change
54.86%
Ranking
Category
Stock Price
$12.74
Market Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has decreased from $829.45M to $771.10M, a decrease of -7.03%. That is a compound annual growth rate of -1.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 771.10M | 26.11% |
| Dec 31, 2025 | 611.44M | -13.79% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
| Jan 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sana Biotechnology | 829.96M |
| Adlai Nortye | 819.19M |
| Arbutus Biopharma | 815.45M |
| ARS Pharmaceuticals | 811.26M |
| Inventiva | 804.29M |
| Omeros | 779.91M |
| MapLight Therapeutics | 766.34M |
| MannKind | 761.01M |